Encompass Health
About: Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
Employees: 28,572
0
Funds holding %
of 7,323 funds
–
Analysts bullish %
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
9% more capital invested
Capital invested by funds: $8.84B [Q4 2024] → $9.63B (+$790M) [Q1 2025]
3% more repeat investments, than reductions
Existing positions increased: 199 | Existing positions reduced: 193
2% more first-time investments, than exits
New positions opened: 60 | Existing positions closed: 59
0.59% less ownership
Funds ownership: 95.02% [Q4 2024] → 94.42% (-0.59%) [Q1 2025]
7% less call options, than puts
Call options by funds: $11.9M | Put options by funds: $12.8M
2% less funds holding
Funds holding: 541 [Q4 2024] → 532 (-9) [Q1 2025]
17% less funds holding in top 10
Funds holding in top 10: 6 [Q4 2024] → 5 (-1) [Q1 2025]
Research analyst outlook
2 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$135
23%
upside
Avg. target
$135
23%
upside
High target
$135
23%
upside
2 analyst ratings
2 positive
100%
0 neutral
0%
0 negative
0%
Stephens & Co. Raj Kumar | 23%upside $135 | Overweight Reiterated | 5 Jun 2025 |
Keybanc Paul Knight | 23%upside $135 | Overweight Maintained | 27 May 2025 |
Financial journalist opinion
Based on 24 articles about EHC published over the past 30 days
Neutral
GlobeNewsWire
19 hours ago
ENCOMPASS INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Continuing Investigating Encompass Health Corporation on Behalf of Encompass Stockholders and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C. Litigation Partners Encourage Investors Who Suffered Losses In Encompass (EHC) To Contact Him Directly To Discuss Their Options
Neutral
GlobeNewsWire
2 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Encompass Health Corporation - EHC
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980.
Positive
Zacks Investment Research
2 days ago
Encompass Health (EHC) Reports Next Week: Wall Street Expects Earnings Growth
Encompass Health (EHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Neutral
PRNewsWire
3 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Encompass Health Corporation - EHC
NEW YORK , July 27, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation ("Encompass" or the "Company") (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Neutral
PRNewsWire
6 days ago
Encompass Health increases and declares dividend on common stock
BIRMINGHAM, Ala. , July 24, 2025 /PRNewswire/ -- Encompass Health Corp. (NYSE:EHC) today announced that its board of directors approved an increase in the Company's quarterly dividend of $0.02 and declared a quarterly cash dividend on its common stock of $0.19 per share, payable on Oct. 15, 2025, to holders of record on Oct. 1, 2025.
Neutral
PRNewsWire
6 days ago
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Encompass Health Corporation (NYSE: EHC) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
NEWTOWN, Pa. , July 23, 2025 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Encompass Health Corporation ("Encompass") (NYSE: EHC), resulting from allegations of providing potentially misleading information to the investing public.
Positive
Zacks Investment Research
1 week ago
Why Encompass Health (EHC) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Negative
Zacks Investment Research
1 week ago
Encompass Health (EHC) Loses 10.4% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for Encompass Health (EHC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Neutral
GlobeNewsWire
1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Encompass Health Corporation - EHC
NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Neutral
GlobeNewsWire
1 week ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Encompass Health Corporation - EHC
NEW YORK, July 23, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Encompass Health Corporation (“Encompass” or the “Company”) (NYSE: EHC). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Charts implemented using Lightweight Charts™